Tapewire

OTC · USD

ELTP

ELITE PHARMACEUTICALS INC /NV/

Export transactions ↓
Tapewire entity
5936
SEC CIK
0001053369
Parsed reports
48

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 23, 2017 Filed Feb 27, 2017 23:17 UTC
Dash Barry HDirector
GrantCommon Stock 88,679 $0.23 $19,997.11
Disclosure

SEC source: 0001053369-17-000002 · primary_doc.xml · nonDerivative · entry 1

Dash Barry H · CIK 0001324222 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,254,457

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.